MAML3
Basic information
Region (hg38): 4:139716753-140154184
Previous symbols: [ "TNRC3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAML3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 1 |
Variants in MAML3
This is a list of pathogenic ClinVar variants found in the MAML3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-139719506-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
4-139889445-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
4-139889738-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
4-139889767-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
4-139889880-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
4-139889909-T-TTGC | Benign (Dec 31, 2019) | |||
4-139889992-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
4-139890050-C-T | not specified | Uncertain significance (Jun 13, 2024) | ||
4-139890111-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
4-139890138-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
4-139890157-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
4-139890165-G-C | not specified | Uncertain significance (Feb 21, 2024) | ||
4-139890220-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
4-139890232-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
4-139890265-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
4-139890297-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
4-139890511-A-G | not specified | Uncertain significance (May 23, 2024) | ||
4-139890583-T-C | not specified | Uncertain significance (Mar 23, 2023) | ||
4-139890604-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
4-139890672-G-T | not specified | Uncertain significance (Jan 18, 2022) | ||
4-139890858-C-A | not specified | Uncertain significance (Jun 26, 2023) | ||
4-139890885-T-G | not specified | Uncertain significance (Jan 04, 2022) | ||
4-139890955-C-T | not specified | Uncertain significance (May 13, 2024) | ||
4-139890957-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
4-140152949-C-T | not specified | Uncertain significance (May 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAML3 | protein_coding | protein_coding | ENST00000509479 | 5 | 437432 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000155 | 22445 | 71581 | 31229 | 125255 | 0.577 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.902 | 573 | 637 | 0.899 | 0.0000340 | 7480 |
Missense in Polyphen | 178 | 213.07 | 0.83542 | 2575 | ||
Synonymous | 1.19 | 233 | 257 | 0.906 | 0.0000154 | 2238 |
Loss of Function | 5.68 | 5 | 47.0 | 0.106 | 0.00000248 | 423 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 2.15 | 1.63 |
Ashkenazi Jewish | 1.51 | 0.663 |
East Asian | 1.22 | 0.519 |
Finnish | 1.55 | 0.643 |
European (Non-Finnish) | 1.61 | 0.589 |
Middle Eastern | 1.22 | 0.519 |
South Asian | 1.51 | 0.686 |
Other | 1.52 | 0.615 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. {ECO:0000269|PubMed:12370315, ECO:0000269|PubMed:12386158}.;
- Pathway
- Th1 and Th2 cell differentiation - Homo sapiens (human);Notch signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);NOTCH-Ncore;Notch Signaling Pathway;Pathways Affected in Adenoid Cystic Carcinoma;Canonical and Non-canonical Notch signaling;Notch Signaling Pathway;Notch Signaling Pathway;Notch;Disease;RUNX3 regulates NOTCH signaling;Signal Transduction;Gene expression (Transcription);Transcriptional regulation by RUNX3;Generic Transcription Pathway;RNA Polymerase II Transcription;Notch-HLH transcription pathway;Notch;NICD traffics to nucleus;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH2;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH3;Signaling by NOTCH;TGF-beta super family signaling pathway canonical;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;BMP2 signaling TGF-beta MV;BMP signaling Dro;Diseases of signal transduction;NOTCH1 Intracellular Domain Regulates Transcription
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.595
- rvis_EVS
- 0.03
- rvis_percentile_EVS
- 55.83
Haploinsufficiency Scores
- pHI
- 0.248
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.979
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Maml3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- transcription initiation from RNA polymerase II promoter;Notch signaling pathway;positive regulation of transcription of Notch receptor target;positive regulation of Notch signaling pathway;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;nuclear speck
- Molecular function
- transcription coactivator activity